Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy. [electronic resource]
Producer: 20150121Description: 1280-92 p. digitalISSN:- 1619-7089
- Aged
- Antigens, Surface -- metabolism
- Glutamate Carboxypeptidase II -- metabolism
- Glutamates -- adverse effects
- Humans
- Iodine Radioisotopes -- therapeutic use
- Male
- Middle Aged
- Molecular Targeted Therapy -- adverse effects
- Neoplasm Metastasis
- Organs at Risk -- radiation effects
- Positron-Emission Tomography
- Prostatic Neoplasms -- diagnostic imaging
- Radiometry
- Radiopharmaceuticals -- adverse effects
- Radiotherapy Dosage
- Safety
- Tomography, X-Ray Computed
- Treatment Outcome
- Urea -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.